Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer AJMC, 18 May 2023 ABSTRACT Objectives: Recent advances have created options for first-line (1L) treatment of advanced/metastatic non–small cell…